Literature DB >> 14514590

Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance.

Georges Ha Van1, Hubert Siney, Agnes Hartmann-Heurtier, Sophie Jacqueminet, Françoise Greau, André Grimaldi.   

Abstract

OBJECTIVE: To compare the efficacy, safety, and compliance of a nonremovable fiberglass cast boot and off-loading shoes in the treatment of diabetic plantar ulcers. RESEARCH DESIGN AND METHODS: Patients (n = 93) with noninfected, nonischemic plantar ulcers were included in this prospective nonrandomized study. Treatment used a nonremovable fiberglass cast boot for longer standing and deeper ulcers (n = 42) and a half shoe or heel-relief shoe for other ulcers (n = 51). We evaluated off-loading therapy, compliance, and complications in both groups.
RESULTS: The healing rate was significantly higher with the cast boot than with the off-loading shoe (81 vs. 70%, P = 0.017), with healing times of 68.6 +/- 35.1 vs. 134.2 +/- 133.0 days, respectively, and hazard ratio 1.68 (95% CI 1.04-2.70); complete compliance with treatment was 98 vs. 10% (P = 0.001), respectively. Secondary osteomyelitis developed in 3 patients in the cast boot group and 13 patients in the off-loading shoe group (P = 0.026).
CONCLUSIONS: A nonremovable fiberglass cast boot was effective in healing diabetic plantar ulcers and in decreasing the risk of secondary osteomyelitis. The cast boot forced compliance with off-loading, thus promoting healing.

Entities:  

Mesh:

Year:  2003        PMID: 14514590     DOI: 10.2337/diacare.26.10.2848

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  [Possible interventions in impaired wound healing].

Authors:  S Coerper; S Beckert; H D Becker
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

2.  Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial.

Authors:  Ezio Faglia; Carlo Caravaggi; Giacomo Clerici; Adriana Sganzaroli; Vincenzo Curci; Wanda Vailati; Daniele Simonetti; Francesco Sommalvico
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

3.  The efficacy of removable devices to offload and heal neuropathic plantar forefoot ulcers in people with diabetes: a single-blinded multicentre randomised controlled trial.

Authors:  Sicco A Bus; Jaap J van Netten; Anke Ir Kottink; Erik A Manning; Maximilian Spraul; Arend-Jan Woittiez; Jeff G van Baal
Journal:  Int Wound J       Date:  2017-10-23       Impact factor: 3.315

4.  Trophic ulcers-Practical management guidelines.

Authors:  Vinita Puri; N Venkateshwaran; Nishant Khare
Journal:  Indian J Plast Surg       Date:  2012-05

5.  Treatment of Charcot Neuroarthropathy and osteomyelitis of the same foot: a retrospective cohort study.

Authors:  Martin Berli; Lazaros Vlachopoulos; Sabra Leupi; Thomas Böni; Charlotte Baltin
Journal:  BMC Musculoskelet Disord       Date:  2017-11-16       Impact factor: 2.362

6.  New trends in the orthopaedic management of diabetic foot.

Authors:  Önder I Kılıçoğlu; Mehmet Demirel; Şamil Aktaş
Journal:  EFORT Open Rev       Date:  2018-05-21

7.  Commitment devices in the treatment of diabetic foot ulcers.

Authors:  Gustav Jarl
Journal:  J Foot Ankle Res       Date:  2019-08-19       Impact factor: 2.303

8.  Beyond dichotomous thinking: a process perspective on diabetic foot disease.

Authors:  Gustav Jarl; Lars-Olov Lundqvist
Journal:  Diabet Foot Ankle       Date:  2017-09-28

9.  Methodological considerations of investigating adherence to using offloading devices among people with diabetes.

Authors:  Gustav Jarl
Journal:  Patient Prefer Adherence       Date:  2018-09-12       Impact factor: 2.711

Review 10.  The Role of Foot-Loading Factors and Their Associations with Ulcer Development and Ulcer Healing in People with Diabetes: A Systematic Review.

Authors:  Chantal M Hulshof; Jaap J van Netten; Mirjam Pijnappels; Sicco A Bus
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.